Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED)

v3.20.1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Oct. 31, 2018 $ 189,086 $ 175,415,931 $ (170,170,209) $ 5,434,808 $ (251,377) $ 5,183,431
Balance (in Shares) at Oct. 31, 2018 18,908,632          
Stock option compensation to employees and directors   2,024,664   2,024,664   2,024,664
Stock options and warrants issued to consultants   92,509   92,509   92,509
Common stock issued upon exercise of stock options $ 300 79,500   79,800   79,800
Common stock issued upon exercise of stock options (in Shares) 30,000          
Restricted stock award compensation to employee pursuant to stock incentive plan   1,954,441   1,954,441   1,954,441
Common stock issued pursuant to employee stock purchase plan $ 54 18,506   18,560   18,560
Common stock issued pursuant to employee stock purchase plan (in Shares) 5,411          
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 $ 10,610 4,347,193   4,357,803   4,357,803
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 (in Shares) 1,061,032          
Net loss     (7,419,533) (7,419,533) (122,010) (7,541,543)
Balance at Apr. 30, 2019 $ 200,050 183,932,744 (177,589,742) 6,543,052 (373,387) 6,169,665
Balance (in Shares) at Apr. 30, 2019 20,005,075          
Balance at Jan. 31, 2019 $ 194,702 180,336,763 (175,052,050) 5,479,415 (336,145) 5,143,270
Balance (in Shares) at Jan. 31, 2019 19,470,235          
Stock option compensation to employees and directors   805,104   805,104   805,104
Stock options and warrants issued to consultants   46,290   46,290   46,290
Common stock issued upon exercise of stock options $ 200 56,900   57,100   57,100
Common stock issued upon exercise of stock options (in Shares) 20,000          
Restricted stock award compensation to employee pursuant to stock incentive plan   470,056   470,056   470,056
Common stock issued pursuant to employee stock purchase plan $ 54 18,506   18,560   18,560
Common stock issued pursuant to employee stock purchase plan (in Shares) 5,411          
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 $ 5,094 2,199,125   2,204,219   2,204,219
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 (in Shares) 509,429          
Net loss     (2,537,692) (2,537,692) (37,242) (2,574,934)
Balance at Apr. 30, 2019 $ 200,050 183,932,744 (177,589,742) 6,543,052 (373,387) 6,169,665
Balance (in Shares) at Apr. 30, 2019 20,005,075          
Balance at Oct. 31, 2019 $ 203,317 186,849,299 (181,817,263) 5,235,353 (422,975) 4,812,378
Balance (in Shares) at Oct. 31, 2019 20,331,754          
Stock option compensation to employees and directors   2,019,211   2,019,211   2,019,211
Stock options issued to consultants   112,209   112,209   112,209
Common stock issued upon exercise of stock options $ 439 103,291   103,730   103,730
Common stock issued upon exercise of stock options (in Shares) 43,900          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356   15,452   15,452
Common stock issued pursuant to employee stock purchase plan (in Shares) 9,618          
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 $ 10,941 3,022,894   3,033,835   3,033,835
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 (in Shares) 1,094,063          
Net loss     (5,232,636) (5,232,636) (41,929) (5,274,565)
Balance at Apr. 30, 2020 $ 214,793 192,122,260 (187,049,899) 5,287,154 (464,904) 4,822,250
Balance (in Shares) at Apr. 30, 2020 21,479,335          
Balance at Jan. 31, 2020 $ 208,413 189,646,000 (184,409,806) 5,444,607 (447,007) 4,997,600
Balance (in Shares) at Jan. 31, 2020 20,841,309          
Stock option compensation to employees and directors   1,055,331   1,055,331   1,055,331
Stock options and warrants issued to consultants   54,755   54,755   54,755
Common stock issued upon exercise of stock options $ 250 75,000   75,250   75,250
Common stock issued upon exercise of stock options (in Shares) 25,000          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356   15,452   15,452
Common stock issued pursuant to employee stock purchase plan (in Shares) 9,618          
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 $ 6,034 1,275,818   1,281,852   1,281,852
Common stock issued in at-the-market offering, net of offering expenses of $158,296/$57,324/$152,911/$85,750 (in Shares) 603,408          
Net loss     (2,640,093) (2,640,093) (17,897) (2,657,990)
Balance at Apr. 30, 2020 $ 214,793 $ 192,122,260 $ (187,049,899) $ 5,287,154 $ (464,904) $ 4,822,250
Balance (in Shares) at Apr. 30, 2020 21,479,335